Copyright
©The Author(s) 2022.
World J Clin Cases. Jul 26, 2022; 10(21): 7195-7208
Published online Jul 26, 2022. doi: 10.12998/wjcc.v10.i21.7195
Published online Jul 26, 2022. doi: 10.12998/wjcc.v10.i21.7195
Table 3 Mayo score for ulcerative colitis
Score | Stool frequency (stools/day more than normal) | Rectal bleeding | Mucosal appearance at endoscopy | Physician’s assessment |
0 | Normal | No blood seen | Normal/inactive disease | Normal |
1 | 1-2 | Visible blood in stool < 50% of time | Mild disease | Mild |
2 | 3-4 | Visible blood with stool in > 50% | Moderate disease | Moderate |
3 | > 4 | Passing blood | Severe disease | Severe |
- Citation: Yasmin F, Najeeb H, Naeem U, Moeed A, Koritala T, Surani S. Apheresis: A cell-based therapeutic tool for the inflammatory bowel disease. World J Clin Cases 2022; 10(21): 7195-7208
- URL: https://www.wjgnet.com/2307-8960/full/v10/i21/7195.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i21.7195